U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021036

Marketing Status: Prescription
Active Ingredient: ZANAMIVIR
Proprietary Name: RELENZA
Dosage Form; Route of Administration: POWDER; INHALATION
Strength: 5MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N021036
Product Number: 001
Approval Date: Jul 26, 1999
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top